For US patients

Get Support:
Enroll or Sign-In

Results

TREMFYA® results at 24 weeks

Proven to reduce joint pain, stiffness, and swelling

In two medical studies, more than 5 out of 10 patients treated with TREMFYA® had at least a 20% improvement
in active PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo.

Individual results may vary.

Take on everyday tasks

TREMFYA® can help reduce the joint pain, stiffness, and swelling that make everyday tasks harder to do.
Patients’ ability to perform everyday activities was assessed in a questionnaire. People taking TREMFYA®
showed an overall improvement in their ability to perform daily activities such as:

Result

Dressing &
grooming

Result

Getting up

Result

Washing up

Result

Eating

Result

Reaching

Result

Walking

Result

Eating

Result

Washing up

Result

Walking

Result

Reaching

Result

Gripping

Result

Daily activities

Less fatigue is possible

Treatment with TREMFYA® resulted in improvement in fatigue. Patients’ level of fatigue was assessed using a
questionnaire to measure self-reported tiredness, weakness, and difficulty conducting usual activities due
to fatigue. Patients were asked to indicate their level of fatigue in the seven days prior.

In addition to joint pain, stiffness, and swelling, some psoriatic arthritis patients feel more than just tired.
In fact, in a small study of PsA patients, 73% experienced PsA-related fatigue.*

*Study was performed in Denmark. Fatigue was assessed using a patient-reported questionnaire.

More than joint relief–clearer skin, too

clearerSkin

Psoriatic arthritis patients treated with TREMFYA® saw an improvement in psoriasis skin plaques.

Click here to see results in adults with moderate to severe plaque psoriasis.

TREMFYA® results at 2 years

Less joint pain, stiffness, and swelling is possible even at 2 years

calender

For patients who continued on TREMFYA® for 2 years, a similar percentage (7 out of 10 patients)
saw a 20% improvement in PsA symptoms at 2 years.

At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Individual results may vary.

At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Results may vary.

Individual results may vary.

Result

TREMFYA® Legacy

TREMFYA® has 14+ years of combined clinical research† and 6+ years on the market across indications.

†Based on a clinical trial of TREMFYA® initiated in 2009.

TREMFYA® Safety Information

Ask your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®,
have possible risks involved with treatment, so it’s important to discuss them with your doctor.

TREMFYA® may cause serious side effects, including:

  • Serious allergic reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
    • fainting, dizziness, feeling lightheaded (low blood pressure)
    • swelling of your face, eyelids, lips, mouth, tongue or throat
    • trouble breathing or throat tightness
    • chest tightness
    • skin rash, hives
    • itching
    • fainting, dizziness, feeling lightheaded
      (low blood pressure)
    • swelling of your face, eyelids, lips, mouth,
      tongue or throat
    • trouble breathing or throat tightness
    • chest tightness
    • skin rash, hives
    • itching
  • Infections. TREMFYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.

    Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:

    • fever, sweats, or chills
    • cough
    • shortness of breath
    • blood in your phlegm (mucus)
    • muscle aches
    • warm, red, or painful skin or sores on your body different from your psoriasis
    • weight loss
    • diarrhea or stomach pain
    • burning when you urinate or urinating more often than normal
    • fever, sweats, or chills
    • cough
    • shortness of breath
    • blood in your phlegm (mucus)
    • muscle aches
    • warm, red, or painful skin or
      sores on your body different
      from your psoriasis
    • muscle aches
    • warm, red, or painful skin or
      sores on your body different
      from your psoriasis

    These are not all the possible side effects of TREMFYA®.

    Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.

TREMFYA® may cause serious side effects including:

  • See “What is the most important information I should know about TREMFYA®?”

    The most common side effects of TREMFYA® include:

    • upper respiratory infections
    • joint pain (arthralgia)
    • fungal skin infections
    • headache
    • diarrhea
    • herpes simplex infections
    • injection site reactions
    • stomach flu (gastroenteritis)
    • bronchitis

    These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 800-FDA-1088.

  • See “What is the most important information I should know about TREMFYA®?”

    • The most common side effects of TREMFYA® include:

    • upper respiratory infections
    • joint pain (arthralgia)
    • fungal skin infections
    • headache
    • diarrhea
    • herpes simplex infections
    • injection site reactions
    • stomach flu (gastroenteritis)
    • bronchitis

    These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects.
    You may report side effects to FDA at 1-800-FDA-1088.

    Result

    Get ready for
    your doctor visit

    Get ready for your doctor visit

    Complete this interactive guide and take it with you to your next doctor’s appointment
    to have a more productive discussion about your psoriatic arthritis.

    Making the Most of Your Appointment*

    DDGIcon

    Asking questions is key to good communication with your rheumatologist. But how do you begin discussing treatment for your joint pain, stiffness, and swelling? What’s most important to you? Rheumatologists want to make sure that you have all of your questions answered. That’s why it’s extremely helpful to have talking points prepared.

    This guide is here to help. Complete the short self-assessment below. Once completed, you’ll receive your personalized Doctor Discussion Guide talking points to discuss with your rheumatologist. The self‑assessment is quick and easy.

    Time to complete: 5 minutes

    *This discussion guide is not a diagnostic tool, but it can help prepare you for a conversation with your rheumatologist. Only your doctor can make a diagnosis and it is important to discuss all of your (questions/talking points/symptoms).

    GET STARTED!

    Don't have time? Download/Print now and fill out later.

    *This discussion guide is not a diagnostic tool, but it can help prepare you for a conversation with your rheumatologist. Only your doctor can make a diagnosis and it is important to discuss all of your (questions/talking points/symptoms).

    LEARN MORE ABOUT TREMFYA®

    TREMFYA® is a prescription medicine approved for the treatment of adults with active psoriatic arthritis (PsA). In two medical studies, more than half of patients treated with TREMFYA® had at least a 20% improvement in PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo. Individual results may vary. TREMFYA® is a 100 mg injection given under the skin as directed by your doctor at weeks 0 and 4, and then every 8 weeks. TREMFYA® can be used alone or in combination with a conventional disease-modifying antirheumatic drug (DMARD) (e.g., methotrexate).

    DDGIcon

    LEARN MORE ABOUT TREMFYA®

    TREMFYA® is a prescription medicine approved for the treatment of adults with active psoriatic arthritis (PsA). In two medical studies, more than half of patients treated with TREMFYA® had at least a 20% improvement in PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo. Individual results may vary. TREMFYA® is a 100 mg injection given under the skin as directed by your doctor at weeks 0 and 4, and then every 8 weeks. TREMFYA® can be used alone or in combination with a conventional disease-modifying antirheumatic drug (DMARD) (e.g., methotrexate).

    BEFORE YOU GO, GET THE MOST OUT OF YOUR DOCTOR VISIT:

    Ask Your Rheumatologist Today

    Here are some examples of additional questions to keep in mind for your rheumatologist.

    DDGIcon

    1) What are the treatment options for the symptoms I am experiencing?

    2) Are there any safety issues I need to be aware of?

    3) How often will I be treated with the biologic?

    4) How will I know if I have joint damage?

    5) What is a biologic treatment?

    6) How do biologics work to improve symptoms?

    7) What is the cost of biologic treatments?

    8) Is financial support available for treatments involving biologics?

    9) Are there patient support programs for patients on biologics?

    10) How can we work together to help manage my treatment and condition?

    LEARN MORE ABOUT TREMFYA®

    TREMFYA® is a prescription medicine used to treat adults with active psoriatic arthritis (PsA).

    In two medical studies, more than half of patients treated with TREMFYA® had at least a 20% improvement in active PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo. Individual results may vary.

    TREMFYA® is a 100 mg injection given under the skin as directed by your doctor at weeks 0 and 4, and then every 8 weeks. TREMFYA® can be used alone or in combination with a conventional disease-modifying antirheumatic drug (DMARD) (e.g., methotrexate).

    END OF
    SELF-ASSESSMENT

    Print your responses on this self-assessment and take them with you to your next appointment. Use this guide to drive the conversation, but don’t be afraid to ask whatever is on your mind. Remember, both you and your rheumatologist have the same goal in mind: fewer joint symptoms so you can do more of what you used to do.

    IF YOU HAVE A TREMFYA® PRESCRIPTION:

    Learn how TREMFYA withMe can support you throughout your treatment journey.

    DDGIcon
    arrow

    Back

    arrow

    Next

    Get your own English or Spanish brochure

    Brochure

    This brochure has all the information you should know about TREMFYA®.

    Download Yours Now

    Folleto

    Este folleto tiene toda la información que debe saber sobre TREMFYA®.

    Descarga El Tuyo Ahora
    Result
    Result
    Result
    Result

    Your story can
    make a difference

    Your personal health journey can inspire and help others.
    If you are on TREMFYA®, we want to hear from you! Share your story with us.

    Want to learn more about TREMFYA®?

    Start getting
    personalized support

    Sign Up for Updates
    Upwards arrow icon